1Itamoto T, Asahara T, Kohashi T, et al. Hepatic arterial infusion oflow-dosecisplatin, 5 - fluorouracil for hepatocellular carcinomawith tumor thrombi in the portalvein. Jpn J Cancer Chemother,1999, 26(12): 1832 - 1835
2Chu L, Sutton LM, Peterson Bl, et al. Continuous infusion 5 - FUas first - linetherapy for metastatic brest cancer. J InfusChemother, 1996, 6(4) :211 - 216
3Azim HA. Treatment of metastic brest cancer by naveblinmitoantrone and continuousinfusion 5 - Fu: results of a pilot study.J Infus Chemother, 1996, 6(2): 102 - 106
4Saji S, Aiba K, Araki K, et al. Current status of low - dose CDDP,5 - Fu therapyfor solid malignant tumors- nationwide questionnairesurvey. Jpn J Cancer Chemother, 1997,26(13): 1892 - 1900
6Tsuji A, Morita S, Horimi T, et al. Preliminary clinical evalution oflow- doseCDDP and continuous 5 - FU therapy for advancedgallbladder cancer. Jpn J Cancer Chemother,2000, 27 (2) :233 - 237
7Shimizu Y, Husumi K. Chemotherapy with consecutive low - doseCDDP combined with 5- FU for gynecologic malignancies. Jpn JCancer Chemother, 19999, 26 ( 11 ): 1569 - 1574
8Sakaihara M, Sakai K, Hara Y, et al. Successful treatment of apatient withrecurrent ovarian clear cell adenocarcinoma undercombination chemotherapy of 5 - FU andlow - dose CDDP. Jpn JCancer Chemother, 2000, 27( 1 ): 127 - 130
9Fujinami K, Kubota Y. Combination chemotherapy with 5 - FU andlow - dose CDDP forurogenital tumors. Jpn J Cancer Chemother,1999, 26( 11 ): 1559 - 1563
10Nishino H, Abe K, Ishikawa T, et al. Combined chemotherapy withlow- dosecisplatin, tegafur and ueacil for head and neck squamouscell carcinomas. Jpn J cancerChemother, 1999, 26 ( 11 ): 1617 -1621
